Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago M de Carvalho

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
BMJ Global Health|November 6, 2023
Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in IndiaTiago M de Carvalho, Irene Man, Damien Georges, et al.
Cancer|July 27, 2016
Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysisSigrid V Carlsson, Tiago M de Carvalho, Monique J Roobol, et al.
International Journal of Cancer|October 13, 2017
Summary statement on screening for prostate cancer in EuropeEveline A M Heijnsdijk, Chris H Bangma, Josep M Borràs, et al.
Annals of Internal Medicine|July 16, 2014
Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefitsIris Lansdorp-Vogelaar, Roman Gulati, Angela B Mariotto, et al.
Annals of Internal Medicine|September 5, 2017
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO TrialsAlex Tsodikov, Roman Gulati, Eveline A M Heijnsdijk, et al.
Cancer|December 7, 2017
The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trialsHarry J de Koning, Roman Gulati, Sue M Moss, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
BMJ Global Health|November 6, 2023
Health and economic effects of introducing single-dose or two-dose human papillomavirus vaccination in IndiaTiago M de Carvalho, Irene Man, Damien Georges, et al.
Cancer|July 27, 2016
Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysisSigrid V Carlsson, Tiago M de Carvalho, Monique J Roobol, et al.
International Journal of Cancer|October 13, 2017
Summary statement on screening for prostate cancer in EuropeEveline A M Heijnsdijk, Chris H Bangma, Josep M Borràs, et al.
Annals of Internal Medicine|July 16, 2014
Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefitsIris Lansdorp-Vogelaar, Roman Gulati, Angela B Mariotto, et al.
Annals of Internal Medicine|September 5, 2017
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO TrialsAlex Tsodikov, Roman Gulati, Eveline A M Heijnsdijk, et al.
Cancer|December 7, 2017
The efficacy of prostate-specific antigen screening: Impact of key components in the ERSPC and PLCO trialsHarry J de Koning, Roman Gulati, Sue M Moss, et al.
Pageof 2